Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Reglodi

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Transplantation Proceedings|August 10, 2010
Mice deficient in neuropeptide PACAP demonstrate increased sensitivity to in vitro kidney hypoxiaG Horvath, B Racz, P Szakaly, et al.
Peptides|August 13, 2005
Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosisB Gasz, B Rácz, E Roth, et al.
Journal of Molecular Neuroscience : MN|July 9, 2008
Agonistic behavior of PACAP6-38 on sensory nerve terminals and cytotrophoblast cellsD Reglodi, R Borzsei, T Bagoly, et al.
Regulatory Peptides|November 6, 2007
PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosisB Rácz, B Gasz, F Gallyas, et al.
Neurotoxicity Research|December 29, 2011
Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient miceA Tamas, K Szabadfi, A Nemeth, et al.
Neurotoxicity Research|July 1, 2011
Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivoK Szabadfi, T Atlasz, P Kiss, et al.
Annals of the New York Academy of Sciences|May 22, 2009
Effects of pituitary adenylate cyclase activating polypeptide on the survival and signal transduction pathways in human choriocarcinoma cellsA Boronkai, R Brubel, B Racz, et al.
Journal of Endocrinological Investigation|July 31, 2010
Alterations of pituitary adenylate cyclase-activating polypeptide-like immunoreactivity in the human plasma during pregnancy and after birthD Reglodi, J Gyarmati, T Ertl, et al.
Journal of Molecular Neuroscience : MN|March 20, 2014
Comparative protein composition of the brains of PACAP-deficient mice using mass spectrometry-based proteomic analysisG Maasz, Z Pirger, D Reglodi, et al.
Neuropeptides|July 13, 2010
Impaired nocifensive behaviours and mechanical hyperalgesia, but enhanced thermal allodynia in pituitary adenylate cyclase-activating polypeptide deficient miceK Sándor, V Kormos, B Botz, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Transplantation Proceedings|August 10, 2010
Mice deficient in neuropeptide PACAP demonstrate increased sensitivity to in vitro kidney hypoxiaG Horvath, B Racz, P Szakaly, et al.
Peptides|August 13, 2005
Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosisB Gasz, B Rácz, E Roth, et al.
Journal of Molecular Neuroscience : MN|July 9, 2008
Agonistic behavior of PACAP6-38 on sensory nerve terminals and cytotrophoblast cellsD Reglodi, R Borzsei, T Bagoly, et al.
Regulatory Peptides|November 6, 2007
PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosisB Rácz, B Gasz, F Gallyas, et al.
Neurotoxicity Research|December 29, 2011
Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient miceA Tamas, K Szabadfi, A Nemeth, et al.
Neurotoxicity Research|July 1, 2011
Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivoK Szabadfi, T Atlasz, P Kiss, et al.
Annals of the New York Academy of Sciences|May 22, 2009
Effects of pituitary adenylate cyclase activating polypeptide on the survival and signal transduction pathways in human choriocarcinoma cellsA Boronkai, R Brubel, B Racz, et al.
Journal of Endocrinological Investigation|July 31, 2010
Alterations of pituitary adenylate cyclase-activating polypeptide-like immunoreactivity in the human plasma during pregnancy and after birthD Reglodi, J Gyarmati, T Ertl, et al.
Journal of Molecular Neuroscience : MN|March 20, 2014
Comparative protein composition of the brains of PACAP-deficient mice using mass spectrometry-based proteomic analysisG Maasz, Z Pirger, D Reglodi, et al.
Neuropeptides|July 13, 2010
Impaired nocifensive behaviours and mechanical hyperalgesia, but enhanced thermal allodynia in pituitary adenylate cyclase-activating polypeptide deficient miceK Sándor, V Kormos, B Botz, et al.
Pageof 6